ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2014

Higher Risk of Hypoglycemia with Glimepiride Versus Vildagliptin in Patients with Type 2 Diabetes is not Driven by High Doses of Glimepiride: Divergent Patient Susceptibilities?

Bo Ahrén et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.